Monitoring wound progression to healing in diabetic foot ulcers using three-dimensional wound imaging.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
02 2020
Historique:
received: 05 09 2019
revised: 02 10 2019
accepted: 08 10 2019
pubmed: 21 12 2019
medline: 16 6 2021
entrez: 21 12 2019
Statut: ppublish

Résumé

3D wound imaging has provided clinicians with even greater wound measurement options. No data is available to guide clinicians as to which 3D measurements may yield the most reflective marker of wound progression to healing. A prospective pilot study was undertaken to assess the accuracy of five 3D wound measurements that best reflect metrics of interest to clinicians. Twenty-one diabetic foot ulcers were enrolled from initial ulcer presentation, through to healing. The relationship between mean wound healing measurement variables was examined using linear regression and Pearsons correlation coefficient, in addition to assessing clinician inter-rater reliability of measurements using Intra-class correlation coefficients (ICC). Statistical analysis demonstrated a linear healing slope for each wound measurement as having a value greater than R 0.70 and a statistical significance of p = 0.0001. This suggests that all five wound measurements are useful prognostic markers of wound progression to healing. Low variability of measurements between users indicates good inter-observer reliability. 3D wound measurements demonstrate a linear correlation between the measurement and time to healing. This suggests they could be effective prognostic markers of a wounds progression to healing and closure. It may also provide important early identification of wounds not responding to standard care. Larger studies are required to validate our results.

Identifiants

pubmed: 31859145
pii: S1056-8727(19)31005-0
doi: 10.1016/j.jdiacomp.2019.107471
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107471

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Matthew Malone (M)

High Risk Foot Service, Liverpool Hospital, Locked Bag 7103, Liverpool, NSW 2170, Australia; South West Sydney Limb Preservation and Wound Research, South Western Sydney Local Health District, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia; Western Sydney University, School of Medicine, Infectious Diseases and Microbiology, Sydney, Australia; Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia. Electronic address: matthew.malone@westernsydney.edu.au.

Saskia Schwarzer (S)

High Risk Foot Service, Liverpool Hospital, Locked Bag 7103, Liverpool, NSW 2170, Australia; South West Sydney Limb Preservation and Wound Research, South Western Sydney Local Health District, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia; Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.

Annie Walsh (A)

High Risk Foot Service, Liverpool Hospital, Locked Bag 7103, Liverpool, NSW 2170, Australia; South West Sydney Limb Preservation and Wound Research, South Western Sydney Local Health District, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.

Wei Xuan (W)

Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.

Abdulaziz Al Gannass (A)

National Guard Health Affairs, Department of Surgery, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Hugh G Dickson (HG)

High Risk Foot Service, Liverpool Hospital, Locked Bag 7103, Liverpool, NSW 2170, Australia; South West Sydney Limb Preservation and Wound Research, South Western Sydney Local Health District, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.

Frank L Bowling (FL)

Central Manchester Foundation Trust, University of Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH